Biotech | November 17, 2021
Pfizer seeks EUA from U.S. FDA for Covid-19 drug
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
It is India’s first pneumotach based portable wireless Spirometer for diagnosis of Chronic Obstructive Pulmonary Disorder (COPD)
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
Launching in 2022, its availability will be expanded to the global market
EaseVRx employs the principles of cognitive behavioural therapy and other behavioural therapy techniques for the reduction of pain and pain interference
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
The Indian Pharmacopoeia Commission (IPC) has added 23 new impurities standards and 7 new Indian Pharmacopoeial Reference standards
Two out of three people under the age of 40 are at risk of prediabetes
BRIDGE-1 Comprehensive care programme for Type 1 diabetes and to train 400 physicians and benefit over 1000 children
The aim is to support Pharmacovigilance programme across the countries in the region
Subscribe To Our Newsletter & Stay Updated
